Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
07/10/2026 21:14
BRIEF-Valneva Provides Update On Ixchiq® In The United Kingdom Oct 7 (Reuters) - Valneva SE VLS.PA:
VALNEVA PROVIDES UPDATE ON IXCHIQ® IN THE UNITED KINGDOM
VALNEVA SE - MHRA REVOKES UK MARKETING AUTHORIZATION FOR IXCHIQ
VALNEVA SE - MHRA DECISION NOT ASSOCIATED WITH NEWLY IDENTIFIED SAFETY SIGNAL
VALNEVA SE - NO IXCHIQ PRODUCT REMAINS ON UK MARKET; MINIMAL SALES IMPACT EXPECTED
VALNEVA SE - HAS DECIDED NOT TO APPEAL MHRA DECISION
Source text: ID:nGNX41bCFG
Further company coverage: VLS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valneva SE
See all newsBrief: UK MHRA Withdraws Marketing Authorisation for Ixchiq Chikungunya Vaccine After Safety Review
Valneva falls as UK regulator revokes Ixchiq vaccine authorisation
Brief: Valneva Provides Update On Ixchiq® In The United Kingdom
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency